desk
Share
News Topical, Digital Desk : Glenmark Pharmaceuticals Ltd. announced after market hours on Monday, September 22, 2025, that the company's board will meet on Friday, September 26, 2025, to consider and approve an interim dividend for the fiscal year 2025-26. The company has set a record date for the payment of the interim dividend as Tuesday, September 30, 2025. The company's results for the June quarter were weak.
Glenmark Pharma's profit fell 86.2% year-on-year to ₹46.8 crore, compared to ₹340.2 crore in the same quarter last year. However, the company's revenue increased marginally to ₹3,264 crore, compared to ₹3,244 crore in the same quarter last year. In terms of sales in India, Glenmark Pharma's formulations business generated ₹1,239.9 crore. Share Performance : The company's stock closed down 3.03% at ₹2,022 on Monday. Over the past year, the company's stock has gained 18.08%.
Read More: Chhath Puja Nahay Khay 2025: Do not make these mistakes on Nahay-Khay, pay attention to these things
--Advertisement--
